Not Tagged
roche,novartis
['novartis', 'genentech']
as #asco23 kicks off, and ceos detail how inflation reduction act causing biopharmas to delay launches for small cancer indications, hurting patients 
The leading voice for decision-makers throughout the global biopharma ecosystem. 
Free weekly podcast "BioCentury This Week": https://t.co/6CfHh0mIT6